Cure8 research brief
This mouse study suggests a blueberry-derived anthocyanin plus pectin complex can alter gut microbes and metabolites linked to inflammation, pointing to a dietary approach that might influence ulcerative colitis biology.
Researchers (diet–microbiome and preclinical IBD), adult patients interested in diet-based microbiome interventions
The research used a DSS-induced ulcerative colitis model in mice and administered a defined dose of a C3G–blueberry pectin complex for one week.
The authors report shifts in bacterial groups (increases in Bacteroidetes and Lactobacillus, decreases in Actinobacteria) and changes in metabolic pathways such as arachidonic acid, linoleic acid, and tryptophan metabolism that correlated with reduced inflammatory markers in the model. This is preclinical laboratory research in mice, not a human trial.
Results show biological plausibility for microbiome–metabolite mediated effects of the C3G–pectin complex but do not establish safety, dosing, or effectiveness in people.
Preclinical (mouse) study; not evidence of efficacy or safety in humans.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The study suggests a natural seaweed-derived polysaccharide could modify gut bacteria and immune signaling in ways that reduced experimental colitis, which may interest people looking for microbiota-targeted dietary...
This preclinical study suggests Antarctic krill oil may reduce inflammation and alter the gut microbiome in a mouse model of ulcerative colitis, which could point toward microbiota-targeted nutritional strategies worth...
Vitamin D appears linked to immune regulation, gut barrier health, and the microbiome—processes relevant to IBD and other intestinal disorders. Understanding this could affect how clinicians monitor and study vitamin D...
